In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis ...
Nov 12, 2018
0
0
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...
Aug 30, 2018
0
3
Two drugs that target different mutations showed encouraging results in treating leukemia, according to recent clinical trials published in the New England Journal of Medicine (NEJM) and The Lancet Oncology.
Jul 10, 2018
0
17
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer without influencing the effect of the treatment. Women also feel better if they take a three-month break from the hormone treatment ...
Dec 1, 2017
0
2
Thousands of breast cancer patients at risk of developing aggressive secondary tumours could benefit from a potential new genetic test.
Oct 25, 2017
0
8
Emeritus Professor Sheila Payne from the International Observatory on End of Life Care at Lancaster University helped conduct the study commissioned by the European Association for Palliative Care (EAPC) and published in ...
Sep 5, 2017
0
1
Global childhood cancer rates jumped 13 percent in the decade to 2010 compared to the 1980s, according to a UN-backed study released Wednesday that says the increase may be due in part to improved detection.
Apr 12, 2017
0
14
It's a conversation preoccupying cancer researchers: how do we turn around the declining participation in quality of life studies?
Apr 3, 2017
0
0
A new study from Karolinska Institutet shows that short-course preoperative radiotherapy combined with delayed surgery reduces the adverse side-effects of rectal cancer surgery without compromising its efficacy. The results ...
Feb 10, 2017
0
3
Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies ...
Dec 3, 2016
0
79
